ANTHRAX VACCINE (BIOTHRAX)

Course overview

AVA is U.S. FDA-approved for preexposure prophylaxis of disease caused by Bacillus anthracis (anthrax) in adults 18¿65 years at high risk for occupational exposure. This continuing education module is designed to give the reader/learner an increased understanding of anthrax vaccine. Readers may explore any or all of the topics. One contact hour of continuing education credit is available for those who successfully complete the post-test and evaluation form.